GKOS — Glaukos Corp

Ownership history in Sofinnova Investments, Inc.  ·  2 quarters on record

This page tracks every 13F SEC filing in which Sofinnova Investments, Inc. reported a position in Glaukos Corp (GKOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.4% (2025 Q4)
Avg. % of fund
1.4%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 288,128 -24,866 -7.9% 1.40% $32.5M $112.91
2025 Q3 INITIATED 312,994 — — 1.40% $25.5M $81.55
% of Fund (quarterly)    GKOS price (monthly, adj. close)

Other funds also holding GKOS

As of 2025 Q4 — sorted by position size

BRAIDWELL LP 3Y 3.33% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.02% PFM Health Sciences, LP 3Y 7Y 2.27% Rhenman & Partners Asset Management AB 3Y 7Y 2.22% Resolute Capital Asset Partners LLC 3Y 2.21% Integral Health Asset Management, LLC 3Y 1.82% Exome Asset Management LLC 1.7% Capricorn Fund Managers Ltd 3Y 1.63% Taylor Frigon Capital Management LLC 3Y 7Y 1.62% RIVERBRIDGE PARTNERS LLC 3Y 7Y 1.13%
← Back to Sofinnova Investments, Inc. Holdings